Missing answers deserve a direct question
Suppose the visit service says the medicine comes from a partner. Ask the pharmacy’s name. Find out who made the preparation. Ask whom to call about the medicine and whom to call if it arrives late. Write each name by its role.
FDA notes a gap in some online compounded-drug care: a person may never learn the compounder’s identity or whether its licensing and oversight are appropriate.
The federal status check dated November 3, 2026 also records FDA reports of fraudulent compounded semaglutide and tirzepatide labels, including labels naming pharmacies that did not exist.
Ask for enough detail to check the record yourself. A familiar-looking name or a well-made site is not the answer to that question.
FDA’s online-pharmacy checklist calls for a valid prescription, a U.S. physical address and phone number, an available licensed pharmacist and a state pharmacy license.
Use those details to check the business behind the offer.
Claims that need careful checking
FDA’s guidance treats an approval claim for a compounded drug as misleading. It also rejects calling the preparation an approved drug’s generic or claiming they are the same.
That federal distinction was checked November 3, 2026.
Ask for the exact product and the source behind the claim. If the answer changes the term from approved to registered, return to what each term establishes. The evidence page sets out that difference.
A price is only part of the check. FDA flags unusually deep discounts as a reason for concern, alongside the other signs in its checklist.
Ask what the quote includes and whether the service can answer the licensing, pharmacy and follow-up questions too. Keep the missing answers visible rather than filling them in from the appearance of the advertisement.
Know what happens after the visit
Before a visit, ask how to reach the treating professional afterward. Ask about response arrangements, test results and a change in the plan. Write down the answer in language you can use later.
The Georgia material checked September 28, 2026 requires remote-care patients to receive professional identity and emergency contact details, plus clear urgent-follow-up instructions.
Georgia’s mail-order rules require a way to report delivery problems. They also require protection of the right temperature when a medicine needs it.
A damaged or late delivery belongs in that conversation. Ask the dispensing pharmacy what to do and how it records the problem. Keep the delivery details with its reply.
FDA says storage requirements depend on the product; a blanket statement that all peptides need refrigeration would be wrong.
Take a complaint to the right office
As of the September 28, 2026 process check, complaints about doctors or physician assistants go to the Georgia medical board. Fee disputes are outside that board’s role.
Nurse complaints go through the Secretary of State’s licensing complaint process. Pharmacy complaints go to the Georgia State Board of Pharmacy.
For deceptive consumer sales practices, Georgia’s Consumer Protection Division is a separate route; professional licensing issues belong with the licensing boards.
Use the relevant official page below to read what the office can handle. Set out what happened in date order, keep the exact wording of the offer and distinguish what you know from what you are asking the office to check.
A board complaint is not a route to immediate care. Georgia’s medical board says it does not intervene in a person’s treatment or obtain financial settlements.
If the concern is urgent
MedlinePlus says a severe allergy can threaten life. Its direction for severe symptoms is to call 911 or the local emergency line. Signs can include swelling in the tongue or face and trouble breathing.
That emergency information was checked September 17, 2026.
People can report a product problem to FDA through MedWatch. Filing that report does not provide medical care.
Keep the next question in view.
Return to the Georgia rules